Han Ying
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Han Ying was the founder of Gene Corp., founded in 2021, serving as Director.
Current jobs include Senior Vice President-Science at Gyre Therapeutics, Inc. starting in 2025, and Chief Scientific Officer at Immunotech Biopharm Ltd. Former jobs include Director at Base Therapeutics, Chief Operating Officer at Tactiva Therapeutics LLC from 2021 to 2023, and Member at T-Cure Bioscience, Inc. from 2017 to 2019.
Education includes a doctorate from Stanford University and undergraduate and graduate degrees from Peking University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 31.03.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Technik-/Wissenschafts-/F&E-Leiter | - |
| Unternehmen | Position | Ende |
|---|---|---|
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Geschäftsführer | 01.12.2023 |
T-Cure Bioscience, Inc.
T-Cure Bioscience, Inc. BiotechnologyHealth Technology Develops clinical-stage T cell receptor therapies for the treatment of cancer | Corporate Officer/Principal | 01.01.2019 |
Gene Corp.
Gene Corp. Specialty StoresRetail Trade Operates sundry goods stores | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gene Corp.
Gene Corp. Specialty StoresRetail Trade Operates sundry goods stores | Retail Trade |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Health Technology |
Immunotech Biopharm Ltd.
Immunotech Biopharm Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops, manufactures and commercializes immune cell products for treatments of cancers | Health Technology |
T-Cure Bioscience, Inc.
T-Cure Bioscience, Inc. BiotechnologyHealth Technology Develops clinical-stage T cell receptor therapies for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen